The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Marshall Keith W since 2020.
This trader's CIK number is 1714828.
At the time of last reporting, Marshall Keith W was the Chief Financial Officer of Prometheus Biosciences, Inc.. (stock ticker symbol RXDX).
Also see all insider trading activities at Prometheus Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | HSTO | 0 | $0 | 0 | $0 | 38,500 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RXDX | 0 | $0 | 30,000 | $3,497,400 | 108,162 | $353,302 |
2. Prometheus Biosciences, Inc. (RXDX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-22 | HSTO | Option Ex | 38,500 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-02 | RXDX | Option Ex | 78,162 | 3.10 | 242,302 |
| 2023-04-05 | RXDX | Option Ex | 10,000 | 3.70 | 37,000 |
| 2023-04-05 | RXDX | Sale | 10,000 | 108.42 | 1,084,200 |
| 2023-03-06 | RXDX | Option Ex | 10,000 | 3.70 | 37,000 |
| 2023-03-06 | RXDX | Sale | 10,000 | 122.13 | 1,221,300 |
| 2023-02-15 | RXDX | Option Ex | 5,000 | 3.70 | 18,500 |
| 2023-02-15 | RXDX | Sale | 5,000 | 119.38 | 596,900 |
| 2023-01-17 | RXDX | Option Ex | 5,000 | 3.70 | 18,500 |
| 2023-01-17 | RXDX | Sale | 5,000 | 119.00 | 595,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marshall Keith W (Chief Financial Officer of Prometheus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.